XML 37 R25.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stockholders’ Equity (Tables)
6 Months Ended
Jun. 30, 2024
Equity [Abstract]  
Schedule of various warrants/options issued and outstanding
         
Number of Warrants / Non-plan Options   Exercise Price   Weighted Average Remaining Life (Years)
78,000     $2.90   0.36
544,290  (1)   $3.32   7.01
88,803     $4.50   2.75
25,000     $5.00   1.11
59,202     $9.10   2.75
795,295          

 

(1)Includes 514,290 warrants and 30,000 non-plan options
Schedule of fair value of assumptions
   
Expected volatility 110.51 %
Expected dividends None  
Expected term (in years) 4.87  
Risk free rate 3.35 %
Schedule of stock option activity
                     
    Number of Options   Weighted Average Exercise Price   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value (1) 
Outstanding at beginning of period    1,177,000   $3.75       $ 
Granted        3.45         
Exercised                 
Forfeited    2,500             
Outstanding at end of period    1,174,500   $3.75    8.96   $ 
Exercisable at end of period    1,012,222   $3.62    8.90   $ 

 

(1)The aggregate intrinsic value of options outstanding and options exercisable at beginning of period and as of June 30, 2024 is $0, as all options are out of the money.
Schedule of RSU activity
          
   Number of restricted stock awards   Weighted average grant-date fair value 
Nonvested at beginning of year  $36,585   $179,998 
Granted   15,865    72,027 
Vested   (11,889)   (54,021)
Forfeited        
Nonvested as of June 30, 2024  $40,551   $198,004 
Schedule of common stock shares reserved for future issuance
     
Exercise of warrants   765,295 
Exercise of options unrelated to any Plan   30,000 
Exercise of stock options – 2021 Incentive Award Plan   1,174,500 
Exercise of restricted stock units – 2021 Incentive Award Plan   40,551 
Total shares of common stock reserved for future issuances   2,010,346